Phage Therapy
Sponsors
Adaptive Phage Therapeutics, Inc., Unity Health Toronto, University of California, San Diego, University of Calgary, Barbara Trautner
Conditions
Acinetobacter Baumannii InfectionAsymptomatic BacteriuriaBacteremiaBacterial InfectionsBacteriuriaCovid19Escherichia ColiPeriprosthetic Joint Infection
Phase 1
Bacteriophage Therapy in Patients With Prosthetic Joint Infections
WithdrawnNCT04787250
Start: 2022-10-31End: 2024-05-31Updated: 2022-04-04
Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
WithdrawnNCT05269121
Start: 2022-09-30End: 2024-11-30Updated: 2024-02-22
Phage Therapy for the Treatment of Urinary Tract Infection
Active, not recruitingNCT05537519
Start: 2023-05-01End: 2024-06-30Updated: 2024-03-26
Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
RecruitingNCT06409819
Start: 2025-06-15End: 2027-03-01Target: 32Updated: 2025-08-14
Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection
Active, not recruitingNCT06456424
Start: 2024-11-20End: 2025-11-30Updated: 2025-06-11
Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria
RecruitingNCT06559618
Start: 2025-02-03End: 2028-12-01Target: 30Updated: 2026-05-05
Bacteriophage Therapy for Morganella Morganii Prosthetic Joint Infection
Active, not recruitingNCT06814756
Start: 2025-03-26End: 2026-03-31Target: 1Updated: 2025-06-12
Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection
Not yet recruitingNCT06942624
Start: 2025-05-31End: 2026-06-30Target: 1Updated: 2025-04-24